XERS
Xeris Biopharma Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.20
+0.49%Forward multiples
Based on analyst estimates
- P/E forward
- 40.72x
- P/E 2026E
- —
- P/E 2027E
- 22.87x
- P/E 2028E
- 13.99x
- P/S forward
- 3.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -153.59x
- Price / sales
- 4.46x
- Price / cash flow
- 26.41x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 4.96x
- EV / EBITDA
- 101.31x
- EV / EBIT
- 45.44x
- Market cap
- $1.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026